Status:
COMPLETED
Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function
Lead Sponsor:
Medical Center Alkmaar
Conditions:
Colon Cancer
Eligibility:
All Genders
60-80 years
Phase:
PHASE4
Brief Summary
Ideally, the postoperative inflammatory response is part of a well-orchestrated mechanism that contributes to tissue healing and rapid recovery. An exaggerated uncontrolled inflammatory response, howe...
Eligibility Criteria
Inclusion
- Patients (male or female) undergoing elective laparoscopic surgery for colon cancer
- Age between 60 and 80 years
- BMI between 20 kg/m2 and below 30 kg/m2
- Written informed consent
Exclusion
- Participation in or having participated in another clinical trial within the previous 3 months
- Indications for continuously use of anticoagulant medication and no possibility to stop these medication perioperatively, for example patients with an artificial heart valve
- Pre-operative Hemoglobin\<5.0 mmol/L
- Metastatic disease
- Very poor peripheral venous access
- Current history of inflammatory or infectious disease
- The use of anti-inflammatory drugs
- The use of thyroid medication
- The use of fish oil products or fish consumption more than 2 times a week
- Contra-indication for the use of Omegaven-Fresenius, including:
- General contra-indications for parenteral nutrition
- Allergy to fish or egg protein.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT02231203
Start Date
October 1 2014
End Date
June 1 2016
Last Update
July 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center of Alkmaar
Alkmaar, North Holland, Netherlands